EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Astaxanthin treatment decreases pro‐inflammatory cytokines and improves reproductive outcomes in patients with polycystic ovary syndrome undergoing assisted reproductive technology: A randomized clinical trial

Farzane Fereidouni, Ladan Kashani, Fardin Amidi, Mahshad Khodarahmian, Shahrzad Zhaeentan, Negar Ajabi Ardehjani, Tayebeh Rastegar

Inflammopharmacology · 2024-08 · 32 (4) · 2337-2347

DOI: 10.1007/s10787-024-01504-0 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Inflammopharmacology, online erschienen am 25.06.2024. Verfasst von Farzane Fereidouni und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Xanthophylls, Reproductive Techniques, Assisted, Cytokines. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RESEARCH QUESTION: In a randomized, triple-blind, placebo-controlled clinical trial (RCT), we investigated the effect of astaxanthin (AST) on pro-inflammatory cytokines, oxidative stress (OS) markers, and assisted reproductive technology (ART) outcomes in 44 infertile Polycystic Ovary Syndrome (PCOS) patients. DESIGN: Patients with PCOS were randomly divided into two groups. The intervention group received 6 mg AST, and the control group received placebo daily for 8 weeks. Blood samples were obtained from all patients before and after intervention and follicular fluid (FF) was collected during the ART procedure. Interleukin (IL) -6, IL-1β were evaluated from serum samples and FF and OS markers (malondialdehyde [MDA], catalase [CAT], superoxide dismutase [SOD], and reactive oxygen species [ROS]) were measured from FF. The groups were compared for ART outcomes as well. RESULTS: A significant decrease in IL-6 and IL-1β concentrations (both, P = < 0.01) serum levels was found following AST treatment. FF cytokine levels and OS markers did not differ significantly between the groups. Reproductive outcomes, including the number of oocytes retrieved (P = 0.01), the MII oocyte count (P = 0.007), oocyte maturity rate (MII %) (P = 0.02) and number of frozen embryos (P = 0.03) significantly improved after intervention. No significant differences were found in chemical, clinical and multiple pregnancies between the groups. CONCLUSIONS: AST pretreatment may modify inflammation and improve ART outcomes in PCOS infertile patients. Further investigations are recommended to verify these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeXanthophyllsReproductive Techniques, AssistedCytokinesInfertility, FemaleOxidative StressFollicular FluidHumansFemaleAdultPregnancyInterleukin-1betaTreatment Outcome

Stichwörter der Autor:innen

ARTAstaxanthinInfertilityInflammationOxidative stressPolycystic ovary syndrome

Substanzen

astaxanthineXanthophyllsCytokinesInterleukin-1beta

Autor:innen und Institutionen

  • Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of infertility, Arash Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. trastegar@sina.tums.ac.ir.

Zitieren

APA

Fereidouni, F., Kashani, L., Amidi, F., Khodarahmian, M., Zhaeentan, S., Ardehjani, N. A., & Rastegar, T. (2024). Astaxanthin treatment decreases pro‐inflammatory cytokines and improves reproductive outcomes in patients with polycystic ovary syndrome undergoing assisted reproductive technology: A randomized clinical trial. Inflammopharmacology, 32(4), 2337-2347. https://doi.org/10.1007/s10787-024-01504-0

Vancouver

Fereidouni F, Kashani L, Amidi F, Khodarahmian M, Zhaeentan S, Ardehjani NA, et al. Astaxanthin treatment decreases pro‐inflammatory cytokines and improves reproductive outcomes in patients with polycystic ovary syndrome undergoing assisted reproductive technology: A randomized clinical trial. Inflammopharmacology. 2024;32(4):2337-2347. doi:10.1007/s10787-024-01504-0

BibTeX
@article{Fereidouni2024,
  author = {Fereidouni, Farzane and Kashani, Ladan and Amidi, Fardin and Khodarahmian, Mahshad and Zhaeentan, Shahrzad and Ardehjani, Negar Ajabi and Rastegar, Tayebeh},
  title = {Astaxanthin treatment decreases pro‐inflammatory cytokines and improves reproductive outcomes in patients with polycystic ovary syndrome undergoing assisted reproductive technology: A randomized clinical trial},
  journal = {Inflammopharmacology},
  year = {2024},
  volume = {32},
  number = {4},
  pages = {2337--2347},
  doi = {10.1007/s10787-024-01504-0}
}
Kostenlos starten →